Brought to you by 
Varian buys Sirtex for $1.3bn; acquistion terminated
28 May 2021
Executive Summary
Varian Medical Systems Ltd. offered $A28 ($22.66) per share, or $A1.6bn, to acquire Australian radioembolization firm Sirtex Medical Ltd. The price paid represents a 57% premium over the ten-day pre-announcement trading average for Sirtex shares.
Deal Industry
- Medical Devices
-
Pharmaceuticals
- Radiopharmaceuticals, Contrast Agents
-
Medical Devices
- Implantable Devices
Deal Status
- Withdrawn
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Cash for Equity
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Varian buys Sirtex for $1.3bn; acquistion terminated
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice